LAENKYN Trademark

Trademark Overview

On Monday, January 9, 2023, a trademark application was filed for LAENKYN with the United States Patent and Trademark Office. The USPTO has given the LAENKYN trademark a serial number of 97747032. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, September 20, 2024. This trademark is owned by Bayer Aktiengesellschaft. The LAENKYN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for humans, namely, treatment for gynecological related diseases, disorders, and deficiencies
laenkyn

General Information

Serial Number97747032
Word MarkLAENKYN
Filing DateMonday, January 9, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for humans, namely, treatment for gynecological related diseases, disorders, and deficiencies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Thursday, January 12, 2023NEW APPLICATION ENTERED
Friday, January 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 13, 2023ASSIGNED TO EXAMINER
Tuesday, July 18, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 18, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, July 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 18, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, July 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 4, 2024SOU EXTENSION 1 FILED
Thursday, April 4, 2024SOU EXTENSION 1 GRANTED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU EXTENSION 2 FILED
Friday, September 20, 2024SOU EXTENSION 2 GRANTED

Related Keywords

laenkyn related diseases disorders deficiencies gynecological treatment preparations humans namely pharmaceutical